Objective: Divalproex extended release (ER) tablets have lower bioavailability than conventional divalproex tablets. Objectives were to provide dose-increment justification for conversion of a ...

2019 that modified or sustained release form of a drug including gastro-resistant tablets/capsules/delayed release tablets/capsules (enteric coated tablets/capsules) or novel drug delivery system ...

Objective: To investigate the relative bioavailability and bioequivalence, in fasting and fed conditions, of repeated doses of two omeprazole enteric-coated ... C serology; drugs of abuse screen ...